{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:09:54Z","timestamp":1783091394051,"version":"3.54.6"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajoc.2024.102233","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:20:09Z","timestamp":1734654009000},"page":"102233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"Llwyatt K.","family":"Hofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaila A.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3929-9571","authenticated-orcid":false,"given":"Jill A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2024.102233_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.1992.01680110104016","article-title":"Necrobiotic xanthogranuloma","volume":"128","author":"Mehregan","year":"1992","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102233_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0190-9622(80)80189-7","article-title":"Necrobiotic xanthogranuloma with paraproteinemia","volume":"3","author":"Kossard","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajoc.2024.102233_bib3","unstructured":"Hernandez-Siman J, Silkiss R. Necrobiotic xanthogranuloma. EyeNet Magazine. Published online March 2017. https:\/\/www.aao.org\/eyenet\/article\/necrobiotic-xanthogranuloma."},{"issue":"1","key":"10.1016\/j.ajoc.2024.102233_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2009.03912.x","article-title":"Necrobiotic xanthogranuloma","volume":"48","author":"Spicknall","year":"2009","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102233_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9394(99)00469-9","article-title":"Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement","volume":"129","author":"Ugurlu","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102233_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02291-z","article-title":"Systemic therapy of necrobiotic xanthogranuloma: a systematic review","volume":"17","author":"Steinhelfer","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajoc.2024.102233_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2023.07.024","article-title":"Ulcerating necrobiotic xanthogranuloma: a clinical sign to reconsider progression from MGUS to multiple myeloma","volume":"40","author":"Fay","year":"2023","journal-title":"JAAD case reports"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102233_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00277-016-2604-3","article-title":"Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone","volume":"95","author":"Dholaria","year":"2016","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.ajoc.2024.102233_bib9","first-page":"678","article-title":"Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy","volume":"11","author":"Ghani","year":"2013","journal-title":"Clin Adv Hematol Oncol: H&O"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102233_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/ced.13293","article-title":"Necrobiotic xanthogranuloma treated with lenalidomide","volume":"43","author":"Mahendran","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102233_bib11","first-page":"273","article-title":"Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide","volume":"9","author":"Silapunt","year":"2010","journal-title":"J Drugs Dermatol JDD: J Drugs Dermatol JDD"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102233_bib12","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00277-018-3301-1","article-title":"Necrobiotic xanthogranuloma: a 30-year single-center experience","volume":"97","author":"Hilal","year":"2018","journal-title":"Ann Hematol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:27:01Z","timestamp":1739780821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":12,"alternative-id":["S2451993624002433"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102233","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102233"}}